17th International Meeting of the European Society of Gynaecological Oncology (ESGO)
Webcasted Presentation

Search’n Build™

PHASE 2 RANDOMIZED PLACEBO-CONTROLLED STUDY OF OLAPARIB (AZD2281) IN PATIENTS WITH PLATINUM-SENSITIVE RELAPSED SEROUS OVARIAN CANCER (PSR SOC)

Prof. Jonathan A Ledermann
Prof. Jonathan A Ledermann
United Kingdom  
Disclosure : Research grant from AstraZeneca
[More] [Less]
24 slide(s) – 00:09:49 – English – 2011-09-12
Extra Features Available

VIDEO PODCAST

SLIDE LIBRARY
A A A  
Rate: Not useful Somewhat useful Mostly useful Useful Very useful

Please let us know how useful this content was for you
and feel free to write your comments below.